Formulations for mediating inflammation and for reducing blood cholesterol
CA 2521254 C · Owner: Mti Meta Tech Inc. · Inventors: Clandinin, Michael Thomas; Park, Eek J.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention provides formulations for mediating inflammation and for lowering blood cholesterol. For example inflammation of the intestine, retina or neural tissues, may be mediated. Further the formulations are effective in decreasing blood cholesterol absorption. The formulations comprise at least one ganglioside, which may be selected from the group consisting of: GD3 GM1, GM2, GM3, GD1b, NANA, and sialic acid. The invention further provides a method of treating or preventing inflammatory diseases by delivery of at least one ganglioside to a subject in need thereof and a method of reducing blood , cholesterol in a subject be delivery of a ganglioside-containing formulation. The …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 12, 2004 and granted March 13, 2012. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 12, 2024.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 12, 2026.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.